Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial ; volume:16 ; number:1 ; day:12 ; month:10 ; year:2017 ; pages:1-12 ; date:12.2017
Cardiovascular diabetology ; 16, Heft 1 (12.10.2017), 1-12, 12.2017
- Schlagwort
-
Kardiovaskuläre Krankheit
- Urheber
-
Natali, Andrea
- Beteiligte Personen und Organisationen
-
Nesti, Lorenzo
Fabiani, Iacopo
Calogero, Enrico
Di Bello, Vitantonio
SpringerLink (Online service)
- DOI
-
10.1186/s12933-017-0615-6
- URN
-
urn:nbn:de:1111-2017120711623
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Natali, Andrea
- Nesti, Lorenzo
- Fabiani, Iacopo
- Calogero, Enrico
- Di Bello, Vitantonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subclinical neuropsychiatric dysfunctions in female patients with systemic lupus erythematosus
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Assessment of subclinical myocardial dysfunctions in Egyptian children with celiac disease, a cross-sectional study
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy
Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension
Effects of empagliflozin on reproductive system in men without diabetes
Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial
The effect of hyperlipidemia and body fat distribution on subclinical left ventricular function in obesity: a cardiovascular magnetic resonance study
Subclinical neuropsychiatric dysfunctions in female patients with systemic lupus erythematosus
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Assessment of subclinical myocardial dysfunctions in Egyptian children with celiac disease, a cross-sectional study
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy
Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension
Effects of empagliflozin on reproductive system in men without diabetes
Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial
The effect of hyperlipidemia and body fat distribution on subclinical left ventricular function in obesity: a cardiovascular magnetic resonance study
Subclinical neuropsychiatric dysfunctions in female patients with systemic lupus erythematosus
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Assessment of subclinical myocardial dysfunctions in Egyptian children with celiac disease, a cross-sectional study
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy
Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension
Effects of empagliflozin on reproductive system in men without diabetes
Association of left ventricular longitudinal myocardial function with subclinical right ventricular dysfunction in type 2 diabetes mellitus
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial